US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Avalon GloboCare Corp. - Common Stock
(NQ:
AVCO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 9, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avalon GloboCare Corp. - Common Stock
< Previous
1
2
3
Next >
Avalon Globocare Corps (NASDAQ: AVCO) Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients. AVCO could be the next big Biotech
January 26, 2022
Via
Viz Release
Topics
Artificial Intelligence
NASDAQ Company offers Life Saving Medical Advances; AI & Immunotherapy for Cancer & Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
January 20, 2022
Via
Get News
Topics
Artificial Intelligence
NASDAQ Company offers Life Saving Medical Advances; AI and Immunotherapy for Cancer and Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
January 20, 2022
Via
Viz Release
Topics
Artificial Intelligence
Year End Update for this Up & Coming NASDAQ at the forefront of innovations in healthcare Featuring AI & Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is AVCO the Next BFRI?
January 10, 2022
Via
Get News
Topics
Artificial Intelligence
Year End Update for this Up and Coming NASDAQ at the forefront of innovations in healthcare Featuring AI and Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is AVCO the Next BFRI?
January 10, 2022
Via
Viz Release
Topics
Artificial Intelligence
NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)
December 09, 2021
Via
Viz Release
This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields Planned:
November 15, 2021
Via
Get News
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
December 28, 2021
Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
NASDAQ at the forefront of innovations in healthcare. Avalon GloboCare Corp. (NASDAQ:AVCO): AVCO’s Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
December 22, 2021
Via
Get News
NASDAQ at the forefront of innovations in healthcare. Avalon GloboCare Corp. (NASDAQ:AVCO): AVCO's Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
December 22, 2021
Via
Viz Release
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 16, 2021
Gainers Eloxx Pharmaceuticals (NASDAQ:
Via
Benzinga
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO)
December 16, 2021
Via
Get News
Topics
Artificial Intelligence
Economy
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO), Palantir Technologies (NYSE: PLTR) and Nvidia (NVDA) lead the Charge and Artificial Intelligence (AI) is at the forefront of innovations in healthcare.
December 16, 2021
Via
Viz Release
Topics
Artificial Intelligence
NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)
December 10, 2021
Via
Get News
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 09, 2021
Gainers Applied DNA Sciences (NASDAQ:APDN...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 07, 2021
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion....
Via
Benzinga
20 Stocks Moving in Monday's Pre-Market Session
↗
November 29, 2021
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results...
Via
Benzinga
This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer & Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
October 13, 2021
Via
Get News
This NASDAQ has Life Saving Advances in Today's Most Critical Bio-Science Fields of Cancer and Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO)
October 13, 2021
Via
Viz Release
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 07, 2021
Gainers Vaxart (NASDAQ:VXRT) shares incr...
Via
Benzinga
Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
↗
October 07, 2021
Image Provided by Pixabay Cytokine storm has made frequent appearances in the news lately as a life-threatening complication in patients suffering from COVID-19. The condition is...
Via
Benzinga
Avalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T Treatment
↗
September 30, 2021
Image Provided by Pexels With a compound annual growth rate (CAGR) of 34.2%, the global CAR-T cell therapy market is projected to hit $15.4 billion by 2028. This hypergrowth is...
Via
Benzinga
Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
↗
September 29, 2021
Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain...
Via
Benzinga
AVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO
September 08, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 02, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 01, 2021
Gainers INmune Bio (NASDAQ:INMB) shares ...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 23, 2021
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 18, 2021
Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading volume for PharmaCyte Biotech's stock is 144.3...
Via
Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KRG, ALTA, AVCO, ICBK; Shareholders are Encouraged to Contact the Firm
July 20, 2021
NEW YORK, NY / ACCESSWIRE / July 20, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Kite Realty Group Trust (NYSE:KRG) concerning...
From
Halper Sadeh LLP
Via
AccessWire
Topics
Fraud
< Previous
1
2
3
Next >
